期刊介绍英文：
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.
期刊介绍中文：
《生物工程和生物技术前沿》已被国际权威数据库SCIE收录，WOS分区等级：1区，中科院SCI期刊分区（2023年12月最新升级版）：工程技术3区。
在当今世界,一个增强的多学科专家之间的交流,促进合作项目和科学家密切合作、工程师、行业的人来说,监管机构和医生是绝对要求任何尝试的成功开发和临床应用一个新的生物疗法或一个创新的设备涉及集体使用生物材料、细胞和/或生物活性分子。《生物工程和生物技术前沿》渴望成为所有参与这一过程的人的论坛，弥合基础科学发现和临床应用之间经常存在的差距。
编辑部地址：
AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, SWITZERLAND, CH-1015
反馈
扫码关注我们
京公网安备 11010802042870号
京ICP备2023020795号-1
2255
分享
订阅
查看最新文献